Dr Reddy’s Laboratories has launched the United States Food & Drug Administration (FDA)  approved memantine hydrochloride tablets  USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCl) tablets in the US market on July  12, 2015.


The Namenda (memantine HCl) tablets brand had US sales of approximately $ 1.4 billion MAT for the most recent twelve months ending in May 2015 according to IMS Health.

Dr Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.